RT Journal Article
SR Electronic
T1 The OMERACT MRI Inflammatory Arthritis Group: Advances and Future Research Priorities
JF The Journal of Rheumatology
JO J Rheumatol
FD The Journal of Rheumatology
SP 1803
OP 1805
DO 10.3899/jrheum.090349
VO 36
IS 8
A1 PHILIP G. CONAGHAN
A1 PAUL BIRD
A1 FIONA McQUEEN
A1 CHARLES PETERFY
A1 PERNILLE BØYESEN
A1 FRÉDÉRIQUE GANDJBAKHCH
A1 ANNE DUER-JENSEN
A1 ESPEN A. HAAVARDSHOLM
A1 BO EJBJERG
A1 CHARLOTTE WIELL
A1 LAURA COATES
A1 KAY-GEERT A. HERMANN
A1 PHILIP O’CONNOR
A1 MARISSA LASSERE
A1 JANE E. FREESTON
A1 ALLEN ANANDARAJAH
A1 HARRY GENANT
A1 PAUL EMERY
A1 MIKKEL ØSTERGAARD
YR 2009
UL http://www.jrheum.org/content/36/8/1803.abstract
AB The OMERACT magnetic resonance imaging (MRI) in inflammatory arthritis group previously developed the rheumatoid arthritis MRI score (RAMRIS) for use in clinical studies, evaluated the use of extremity MRI, and initiated development of a psoriatic arthritis MRI score (PsAMRIS). At OMERACT 9 the group looked at clarifications of applying the RAMRIS, and presented data from a study examining how the contrast agent gadolinium affects RAMRIS outcomes. Much of the group’s effort has been aimed at the iterative development of its PsA score, and reported exercises examining this score demonstrated encouraging results, allowing subsequent presentation of a preliminary PsAMRIS. The large amount of data presented were followed by discussions with the wider audience highlighting constructive suggestions for future research priorities, including further feasibility studies, understanding imaging remission, and further improvements to PsAMRIS.